Home
Valuation

Work Area: Valuation

How a patent dispute with 10x helped decimate NanoString’s stock price

Recent $31 million damages award has dealt a further blow to the company's faltering share value

IP disclosure requirements are changing – and that is a good thing

Saturday Opinion: Founder of Sauvegarder Investment Management, Erich Spangenberg, urges patent owners to break with tradition and better explain to clients and investors why they should care about these assets

Is Japan ready to stop patent hoarding and start exploiting its vast intangible resources?

Saturday Opinion: IPDefine CEO Aaron Mollin says change is afoot in the willingness of IP teams in some of the largest companies to use AI for portfolio-wide patent optimisation and monetisation initiatives

Latest content

IP could become a $100 billion premium market, says Aon CEO

Greg Case has been bullish about the sector for a while and if he is right it could finally mean the birth of the asset class so many have been waiting for

30 August 2021

Pfizer’s $2.3 billion spend on CD47 inhibitors shows how oncology IP continues to drive pharma deal-making

The acquisition of the cutting-edge haematology candidates is just the latest development in the booming immuno-oncology market

26 August 2021

Toyota’s self-driving haul from Lyft includes 100+ US patent assets

Patents change hands after Japanese carmaker buys Lyft’s self-driving tech for $550 million

23 August 2021

Japan’s corporate watchdog calls for high-level emphasis on intellectual property

Changes to the country’s corporate governance code encourage boards to pay more attention to IP strategy

18 August 2021

mRNA IP will be hot property beyond the pandemic

$3.2 billion Sanofi deal is unlikely to be the last as Big Pharma seeks to consolidate its position in the cutting-edge field

12 August 2021

Healthcare Royalty Partners’ $750 million IPO to be next milestone for a booming market

The company is hoping to raise cash to help expand its purchasing power when acquiring pharmaceuticals revenue streams

05 August 2021

Investor interest in IP is about more than big money verdicts, claims Ocean Tomo transactions chief

Ten-figure awards in the patent space have caught capital’s attention, says Ocean Tomo's Ryan Zurek, but so has the IP market’s resilience in the face of economic turbulence

04 August 2021

Biopharma M&A has fallen off a cliff – but IP owners in the sector have reasons to be cheerful

The number and value of acquisitions have both tumbled further than in the early months of 2020

20 July 2021

Singapore banking on regional IP rise and dispute resolution to cement its hub status

An update to the country’s strategy recognises that facilitating ASEAN's patenting development is key

19 July 2021

IAM insight panel analysis Q2 2021

Featured in Community Insight

Second quarter panels report finds a marked increase in negative views about the administration, but fewer covid concerns and signs of higher royalty and sales prices

01 July 2021

Unlock unlimited access to all IAM content